vTv Therapeutics Inc.
Develops oral small molecule drugs for type 1 diabetes and other chronic conditions.
VTVT | US
Overview
Corporate Details
- ISIN(s):
- US9183852048
- LEI:
- Country:
- United States of America
- Address:
- 3980 PREMIER DR, 27265 HIGH POINT
- Website:
- https://vtvtherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
vTv Therapeutics Inc. is a late-stage biopharmaceutical company focused on the development of oral, small molecule drug candidates. The company's clinical pipeline is led by cadisegliatin, a potential first-in-class oral therapy designed as an adjunctive treatment to insulin for patients with type 1 diabetes. In collaboration with development partners, vTv Therapeutics also pursues additional indications for its drug candidates, including type 2 diabetes and other chronic conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all vTv Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for vTv Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for vTv Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
